InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,475.31
(
0.04%
)
US TECH 100
19,356.80
(
-0.24%
)
Dow Jones
38,755.74
(
-0.06%
)
Brent Oil
84.52
(
0.74%
)
Bitcoin
64,714.73
(
-2.67%
)
Post# of 252237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

steveporsche

Send PM Follow Ignore
Followers 2
Posts 283
Boards Moderated 0
Alias Born 08/25/2006

steveporsche

Re: None

Monday, 12/20/2010 7:29:37 AM

Monday, December 20, 2010 7:29:37 AM

Post# of 252237
MNTA - Goldman Sachs starts coverage with a Neutral Rating and a 12-Month Price Target of $15

(sorry I do not have a link - appeared on my trading platform news page) Sees the company benefitting from evolving landscape of biosimilars but upside capped by threat of another company entering generic Lovenox market.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up